Gan To Kagaku Ryoho. 2010 Mar;37(3):527-9.

[A case of metastatic pancreatic cancer with a remarkable response to combination therapy of gemcitabine and adoptive immune cell therapy].

[Article in Japanese]

Imai N, Takeda K, Utsunomiya S, Taga M, Kawata N, Ikeda T, Mizutani Y, Hirose K, Ishikawa T, Yoshida S.

Source

Dept. of Gastroenterology, Nagoya Kyoritsu Hospital.

Abstract

A 52-year-old woman with a chief complaint of epigastric distress was diagnosed as having pancreatic cancer with multiple liver metastases. After insertion of a metallic stent for biliary stenosis, combination therapy of gemcitabine (GEM) and adoptive immune cell therapy (AICT) was initiated. GEM 1,000 mg/m2 was administered on day 1, 8 and 15 every 4 weeks, while AICT using MUC1 peptide-pulsed dendritic cells (DC) and anti-CD3-activated T lymphocytes (CAT) was given biweekly. After 6 courses of GEM and 9 courses of DC-CAT, the patient was considered to have a complete response (CR) on CT and MRI examination. CR has still been maintained by the continuous administration of GEM and CAT. The combination therapy of GEM and AICT was suggested to be effective against advanced pancreatic cancer.

PMID:: 20332697; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Sunmedia PierOnline

Medical

Supplemental Content

Related citations

A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer. [Pancreas. 2009]
A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer.
Hirooka Y, Itoh A, Kawashima H, Hara K, Nonogaki K, Kasugai T, Ohno E, Ishikawa T, Matsubara H, Ishigami M, et al. Pancreas. 2009 Apr; 38(3):e69-74.
[A case of liver metastasis of pancreatic duct carcinoma successfully treated with gemcitabine]. [Gan To Kagaku Ryoho. 2003]
[A case of liver metastasis of pancreatic duct carcinoma successfully treated with gemcitabine].
Tsujie M, Nakamori S, Nakazuru S, Hayashi N, Okami J, Nagano H, Dono K, Umeshita K, Sakon M, Monden M. Gan To Kagaku Ryoho. 2003 Feb; 30(2):297-301.
[Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years]. [Gan To Kagaku Ryoho. 2004]
[Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years].
Yajima T, Furukawa Y, Ishii Y, Hattori Y, Matsumoto N, Yamamoto M, Yamaoka Y, Fujihara M, Fujita M, Kuniki H. Gan To Kagaku Ryoho. 2004 Jun; 31(6):953-7.
Review [Chemotherapy for pancreatic cancer]. [Gan To Kagaku Ryoho. 2003]
Review [Chemotherapy for pancreatic cancer].
Sunamura M, Egawa S, Fukuyama S, Motoi F, Takeda K, Akada M, Ottomo S, Abe H, Matsuno S. Gan To Kagaku Ryoho. 2003 Nov; 30(12):1901-8.
Review [Results of gemcitabine hydrochloride in the treatment for pancreatic cancer]. [Gan To Kagaku Ryoho. 2001]
Review [Results of gemcitabine hydrochloride in the treatment for pancreatic cancer].
Tsukagoshi S. Gan To Kagaku Ryoho. 2001 Oct; 28(10):1461-7.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

[A case of metastatic pancreatic cancer with a remarkable response to combinatio...
[A case of metastatic pancreatic cancer with a remarkable response to combination therapy of gemcitabine and adoptive immune cell therapy].
Gan To Kagaku Ryoho. 2010 Mar ;37(3):527-9.

PubMed
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine ...
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours.
Br J Cancer. 2010 Mar 30 ;102(7):1106-12. Epub 2010 Mar 16 .

PubMed
Safety and efficacy of single-day GemOx regimen in patients with pancreatobiliar...
Safety and efficacy of single-day GemOx regimen in patients with pancreatobiliary cancer: a single institution experience.
Expert Opin Drug Saf. 2010 Mar ;9(2):207-13.

PubMed
An FMRI investigation of spontaneous mental state inference for moral judgment.
An FMRI investigation of spontaneous mental state inference for moral judgment.
J Cogn Neurosci. 2009 Jul ;21(7):1396-405.

PubMed
Comparison of otoplasty outcomes using different types of suture materials.
Comparison of otoplasty outcomes using different types of suture materials.
Int Surg. 2010 Jan-Mar ;95(1):88-93.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

[A case of metastatic pancreatic cancer with a remarkable response to combination therapy of gemcitabine and adoptive immune cell therapy].

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information